Skip to main content
Premium Trial:

Request an Annual Quote

Cell Projects, Queen's University to Develop Electroporation Technologies

NEW YORK (GenomeWeb News) – Cell Projects has signed a licensing and joint development agreement with Queen’s University in Ontario, Canada, to develop new electroporation technologies for adherent and in situ cell electroporation.
 
According to a statement released yesterday by Maidstone, UK-based Cell Projects, the new technology allows DNA, peptides, siRNA, and other molecules to be transported into cultured, adherent cells while the cells are still attached to their growing surface.
 
The technology “will enable a greater understanding of specific cellular activities that to date have been difficult to analyze yet are known to be important in further understanding the mechanism of cancer, and other biological problems,” said Tom Hole, managing director of Cell Projects.
 
Financial terms of the alliance were not disclosed.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.